> top > projects > sentences > docs > PubMed:16177264 > annotations
sentences Home  

PubMed:16177264 JSONTXT 67 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-117 Sentence denotes Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
T1 0-117 Sentence denotes Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
T1 0-117 Sentence denotes Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
TextSentencer_T2 118-298 Sentence denotes Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH).
T2 118-298 Sentence denotes Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH).
T2 118-298 Sentence denotes Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH).
TextSentencer_T3 299-454 Sentence denotes Glycan processing is normally perturbed in tumors, therefore we investigated whether changes in glycosylation of PSA could be useful diagnostic indicators.
T3 299-454 Sentence denotes Glycan processing is normally perturbed in tumors, therefore we investigated whether changes in glycosylation of PSA could be useful diagnostic indicators.
T3 299-454 Sentence denotes Glycan processing is normally perturbed in tumors, therefore we investigated whether changes in glycosylation of PSA could be useful diagnostic indicators.
TextSentencer_T4 455-633 Sentence denotes Previously we determined that the glycosylation of PSA secreted by the tumor prostate cell line LNCaP differs significantly from that of PSA from seminal plasma (normal control).
T4 455-633 Sentence denotes Previously we determined that the glycosylation of PSA secreted by the tumor prostate cell line LNCaP differs significantly from that of PSA from seminal plasma (normal control).
T4 455-633 Sentence denotes Previously we determined that the glycosylation of PSA secreted by the tumor prostate cell line LNCaP differs significantly from that of PSA from seminal plasma (normal control).
TextSentencer_T5 634-867 Sentence denotes We therefore undertook a detailed glycan analysis of PSA derived from sera from PCa patients and, importantly, established that the glycosylation of the PCa serum PSA was significantly different from the PSA from the LNCaP cell line.
T5 634-867 Sentence denotes We therefore undertook a detailed glycan analysis of PSA derived from sera from PCa patients and, importantly, established that the glycosylation of the PCa serum PSA was significantly different from the PSA from the LNCaP cell line.
T5 634-867 Sentence denotes We therefore undertook a detailed glycan analysis of PSA derived from sera from PCa patients and, importantly, established that the glycosylation of the PCa serum PSA was significantly different from the PSA from the LNCaP cell line.
TextSentencer_T6 868-1040 Sentence denotes In comparison with seminal plasma PSA, the fucose content of PSA from the PCa patient serum was significantly lower and there was a decrease in alpha2,3-linked sialic acid.
T6 868-1040 Sentence denotes In comparison with seminal plasma PSA, the fucose content of PSA from the PCa patient serum was significantly lower and there was a decrease in alpha2,3-linked sialic acid.
T6 868-1040 Sentence denotes In comparison with seminal plasma PSA, the fucose content of PSA from the PCa patient serum was significantly lower and there was a decrease in alpha2,3-linked sialic acid.
TextSentencer_T7 1041-1263 Sentence denotes Differences in the glycosylation of PSA derived from PCa patients' sera, seminal plasma, and LNCaP cells were further established by lectin detection, glycosylation immunosorbent assay, and two-dimensional electrophoresis.
T7 1041-1263 Sentence denotes Differences in the glycosylation of PSA derived from PCa patients' sera, seminal plasma, and LNCaP cells were further established by lectin detection, glycosylation immunosorbent assay, and two-dimensional electrophoresis.
T7 1041-1263 Sentence denotes Differences in the glycosylation of PSA derived from PCa patients' sera, seminal plasma, and LNCaP cells were further established by lectin detection, glycosylation immunosorbent assay, and two-dimensional electrophoresis.
TextSentencer_T8 1264-1387 Sentence denotes We also investigated whether the impact of glycosylation changes initiated by the tumor was reflected in the serum glycome.
T8 1264-1387 Sentence denotes We also investigated whether the impact of glycosylation changes initiated by the tumor was reflected in the serum glycome.
T8 1264-1387 Sentence denotes We also investigated whether the impact of glycosylation changes initiated by the tumor was reflected in the serum glycome.
TextSentencer_T9 1388-1567 Sentence denotes By comparing the glycans released from the total glycoproteins in PCa patient serum with those of normal serum we found an increase in the proportion of sialyl-Lewis x structures.
T9 1388-1567 Sentence denotes By comparing the glycans released from the total glycoproteins in PCa patient serum with those of normal serum we found an increase in the proportion of sialyl-Lewis x structures.
T9 1388-1567 Sentence denotes By comparing the glycans released from the total glycoproteins in PCa patient serum with those of normal serum we found an increase in the proportion of sialyl-Lewis x structures.
TextSentencer_T10 1568-1788 Sentence denotes Further analysis of the glycosylation of PSA from PCa and BPH sera will be required in order to determine the utility of these glycan differences to discriminate specifically between benign and malignant prostate states.
T10 1568-1788 Sentence denotes Further analysis of the glycosylation of PSA from PCa and BPH sera will be required in order to determine the utility of these glycan differences to discriminate specifically between benign and malignant prostate states.
T10 1568-1788 Sentence denotes Further analysis of the glycosylation of PSA from PCa and BPH sera will be required in order to determine the utility of these glycan differences to discriminate specifically between benign and malignant prostate states.